Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrik Gether

Showing results (121-130 of 177) with videos related to

Pageof 18
Sort By:
Trials|August 13, 2009
Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depressionUlla Knorr, Maj Vinberg, Marianne Klose, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2015
Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKIIThomas Steinkellner, Therese R Montgomery, Tina Hofmaier, et al.
Plos One|July 9, 2011
Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trialUlla Knorr, Maj Vinberg, Allan Hansen, et al.
Nature Neuroscience|June 24, 2008
The binding sites for cocaine and dopamine in the dopamine transporter overlapThijs Beuming, Julie Kniazeff, Marianne L Bergmann, et al.
Elife|January 25, 2017
Direct assessment of substrate binding to the Neurotransmitter:Sodium Symporter LeuT by solid state NMRSimon Erlendsson, Kamil Gotfryd, Flemming Hofmann Larsen, et al.
Molecular Pharmacology|November 6, 2007
Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitorsClaus J Loland, Rajeev I Desai, Mu-Fa Zou, et al.
Plos Computational Biology|November 12, 2016
The Environment Shapes the Inner Vestibule of LeuTAzmat Sohail, Kumaresan Jayaraman, Santhoshkannan Venkatesan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2023
Behavioral encoding across timescales by region-specific dopamine dynamicsSøren H Jørgensen, Aske L Ejdrup, Matthew D Lycas, et al.
Communications Biology|June 10, 2022
Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensorsCarmen Klein Herenbrink, Jonatan Fullerton Støier, William Dalseg Reith, et al.
British Journal of Pharmacology|December 25, 2015
Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporterM Andreas B Larsen, Per Plenge, Jacob Andersen, et al.
Pageof 18

Showing results (121-130 of 177) with videos related to

Sort By:
Pageof 18
Trials|August 13, 2009
Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depressionUlla Knorr, Maj Vinberg, Marianne Klose, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 29, 2015
Amphetamine action at the cocaine- and antidepressant-sensitive serotonin transporter is modulated by αCaMKIIThomas Steinkellner, Therese R Montgomery, Tina Hofmaier, et al.
Plos One|July 9, 2011
Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trialUlla Knorr, Maj Vinberg, Allan Hansen, et al.
Nature Neuroscience|June 24, 2008
The binding sites for cocaine and dopamine in the dopamine transporter overlapThijs Beuming, Julie Kniazeff, Marianne L Bergmann, et al.
Elife|January 25, 2017
Direct assessment of substrate binding to the Neurotransmitter:Sodium Symporter LeuT by solid state NMRSimon Erlendsson, Kamil Gotfryd, Flemming Hofmann Larsen, et al.
Molecular Pharmacology|November 6, 2007
Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitorsClaus J Loland, Rajeev I Desai, Mu-Fa Zou, et al.
Plos Computational Biology|November 12, 2016
The Environment Shapes the Inner Vestibule of LeuTAzmat Sohail, Kumaresan Jayaraman, Santhoshkannan Venkatesan, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2023
Behavioral encoding across timescales by region-specific dopamine dynamicsSøren H Jørgensen, Aske L Ejdrup, Matthew D Lycas, et al.
Communications Biology|June 10, 2022
Multimodal detection of dopamine by sniffer cells expressing genetically encoded fluorescent sensorsCarmen Klein Herenbrink, Jonatan Fullerton Støier, William Dalseg Reith, et al.
British Journal of Pharmacology|December 25, 2015
Structure-activity relationship studies of citalopram derivatives: examining substituents conferring selectivity for the allosteric site in the 5-HT transporterM Andreas B Larsen, Per Plenge, Jacob Andersen, et al.
Pageof 18